increased hemolymphoid system tumor incidence_Jak2<tm1.2Ble>/Jak2<+>

http://metadb.riken.jp/0010296I129S6SvEvTacC57BL6FVBNJak2tm12BleJak2Jak2tm12BleJak2

increased hemolymphoid system tumor incidence_Jak2<tm1.2Ble>/Jak2<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• Janus kinase 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:96629

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Jak2<tm1.2Ble>/Jak2<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Jak2<tm1.2Ble>|Jak2<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S6/SvEvTac * C57BL/6 * FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased hemolymphoid system tumor incidence
  http://purl.obolibrary.org/obo/MP_0010296

文献

http://purl.org/net/cito/citesAsAuthority

• Ann. Mullally, et.al., Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells., Cancer cell, 2010, 17
  http://rdf.ncbi.nlm.nih.gov/pubmed/20541703